000 01529 a2200361 4500
005 20250513091312.0
264 0 _c19960722
008 199607s 0 0 eng d
022 _a0008-543X
024 7 _a10.1002/(SICI)1097-0142(19960501)77:9<1959::AID-CNCR32>3.0.CO;2-X
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAnand, A
245 0 0 _aProspective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma.
_h[electronic resource]
260 _bCancer
_cMay 1996
300 _a1959-60 p.
_bdigital
500 _aPublication Type: Comment; Letter
650 0 4 _aAntibiotics, Antineoplastic
_xadministration & dosage
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aAntineoplastic Agents, Alkylating
_xadministration & dosage
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadministration & dosage
650 0 4 _aCisplatin
_xadministration & dosage
650 0 4 _aCyclophosphamide
_xadministration & dosage
650 0 4 _aDoxorubicin
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aMesothelioma
_xdrug therapy
650 0 4 _aPleural Neoplasms
_xdrug therapy
650 0 4 _aProspective Studies
650 0 4 _aRemission Induction
700 1 _aAnand, A
700 1 _aAnand, N
773 0 _tCancer
_gvol. 77
_gno. 9
_gp. 1959-60
856 4 0 _uhttps://doi.org/10.1002/(SICI)1097-0142(19960501)77:9<1959::AID-CNCR32>3.0.CO;2-X
_zAvailable from publisher's website
999 _c8645736
_d8645736